Junto Health is a team of entrepreneurs who have founded, funded, and advised over 150 technology startups.
We have invested nine figure portfolios, developed strategic partnership at venture-backed startups, and led award-winning accelerators in healthcare & education.
We have worked with over 60 large stakeholders from every vertical of healthcare, regularly convening industry leaders and actively guiding them through the process of co-development, crowdsourced ideation, and creative partnerships.
More importantly, we are entrepreneurs. We have experienced failure, and have the hard-earned scars to prove it.
By combining this hands-on entrepreneurial experience with our deep understanding of large enterprise innovation strategies and our network of customers & capital providers, Junto Health is a trusted commercialization partner for corporate innovation teams.
Head of BUSINESS development
Amelia Edwards is the Head of Business Development at Junto Health. She joined the Junto team at the end of 2016 as a Marketing Fellow and soon advanced to the position of Head of Marketing prior to shifting into her current role. As the Head of Business Development, Amelia interfaces with Junto's clients on large-scale advisory projects, designs workshops & learning sessions, and is responsible for growing Junto's service offerings & partnership programs.
Prior to joining Junto, Amelia worked as a consultant for a health-care education non-profit in India. In this position, she helped design a business and market entry plan to help differentiate the client's products from other medical training programs, as well as refine the offering to reflect gaps in residency training within India's public & national medical programs.
Before this, Amelia had a role at the One Million Community Health Workers Campaign where she assisted with supporting community healthcare worker deployment & training in African nations as a means of increasing care access. Her team specifically was focused on the government healthcare system scale-up in Ghana & Nigeria and how policies and media attention impacted these efforts. While there, she was responsible for researching the logistics for cost-effective deployment of community health workers and widespread mobile health programs. This set her along the path of working within the healthcare technology ecosystem and gaining expertise in digital health.
Amelia received her BA from Columbia University and will soon receive her Master of Public Health (MPH) from Columbia University's Mailman School of Public Health. Her specialities include intervention design, program evaluation, systems thinking, and behavioral economics. Amelia additionally is well versed in venture capital funding models and has been studying how these models can push funding towards technology & innovation for high-risk populations (Medicaid, duel-eligible, low SES).
Founder & CEO
Doug Hayes is the founder & CEO of Junto Health. He works closely with large health systems, global pharmaceutical and insurance companies, venture investors, and entrepreneurs, advising C-level executives on their strategic decisions, facilitating collaborations between complementary stakeholders, and curating senior executives for confidential Summits.
Prior to founding Junto Health, Doug was the Executive Director of Blueprint Health, a health tech accelerator & micro-venture fund based in Soho, New York. Doug worked directly with 65+ startups, guiding them from the whiteboard to their first customers, investors, and advisors. He grew the Blueprint Health Mentor Network to 225+ senior executives, increased application flow to 2,000+ startups annually, and developed strategic partnerships with leading health systems like New York Presbyterian. While serving as Executive Director, Blueprint Health was named as one of the “10 Most Innovative Companies in Health” by Fast Company.
Before joining Blueprint Health, Doug was the founding CFO of the first education technology accelerator in New York City, and led strategic partnerships at a venture backed education technology company, 2U, which co-developed blended learning programs with institutions like Georgetown University and the University of North Carolina.
Doug has been invited to speak at a variety of industry conferences, universities, and corporations, and has served on the advisory boards for global conferences like HealthFrontiers (Berlin) and TechTour’s HIT Summit (Lausanne). He is a Member of Cornell Tech's Health Tech Advisory Council and was the Chairperson of the first Internet of Health Conference in the US; he served on the judging panel for the 2018 Heritage Healthcare Innovation Awards.
Doug started his career as an investor at JP Morgan, where he constructed investment strategies for foundations and HWNI’s. He then went to a private family office, where he served on the investment committee and developed investment strategies across public equities, fixed income, derivatives, and private equity.
Doug received his BA from Dartmouth College, where he founded the Dartmouth Investment & Philanthropy Program (DIPP), the first student-managed investment fund on the East Coast. Under his tenure, the DIPP portfolio outperformed the market and awarded those capital gains to philanthropic programs in New Hampshire's Upper Valley.
Joseph Habboushe, MD, MBA
Co-founder & CEO, MDCalc
Associate Professor of Emergency Medicine, NYU/BellevuE
Dr. Habboushe is a practicing emergency physician in New York City and serial healthcare entrepreneur. He is cofounder of MDCalc, the largest physician-owned medical reference used by approximately 2/3 of U.S. physicians weekly. He is also founder of Vitalis Pharmaceuticals, developing novel therapies in multiple sclerosis, opioid-sparing pain, and cholesterol.
Dr. Habboushe received his M.D. from Cornell University, his M.B.A. in Healthcare Finance from Columbia University, and his B.S. in Applied Mathematics from Yale University.
Gregory Hayes, PhD
director of North America applications & consulting, eos North America
co-founder, complex materials
Greg Hayes is a strategic technology development consultant with a strong background in high-end research and development, and a focus in materials science and engineering. Greg’s professional background began as a consulting materials scientist and technical program lead, working internationally in the health-tech, high-tech, and aerospace markets.
Currently, Greg is director of consulting and applications of EOS North America, where he works to identify market needs and uses of Additive Manufacturing (AM) technology to develop products to fulfill those opportunities. Most recently as a program manager and director of new partnerships for AM at TNO, he concentrated on design and structure of research programs, acquisition of funding and partners, and general management. Earlier in 2014, Greg co-founded Complex Materials, a bespoke bioresorbable materials company with a focus on magnesium alloy stent tubing.
Greg holds an ME degree from the University of Delaware; a Ph.D. in Materials Science from The Pennsylvania State University; and Start-up and Entrepreneurship certification from the Vlerick Business School in Belgium.